Skip to Content

Join the 'Estrostep Fe' group to help and get support from people like you.

Estrostep Fe Blog

Obese Teens Less Likely to Use Birth Control

Posted 6 days ago by Drugs.com

WEDNESDAY, July 1, 2015 – Sexually active teenage girls who are obese are less likely to use birth control than teens who aren't overweight, a new study reports. What's more, those overweight teens who do use some form of contraception are less likely than their normal-weight peers to use it regularly, the researchers said. In both cases, obese teens are at greater risk for an unintended pregnancy, the research from the University of Michigan found. "The U.S. teen pregnancy rate is one of the highest in the developed world and we know pregnant adolescents are more likely to have poor birth outcomes," said the study's lead author, Dr. Tammy Chang, an assistant professor of family medicine at the U-M Medical School and a member of the U-M Institute for Healthcare Policy and Innovation, in a university news release. "Reducing adolescent pregnancy is a national public health priority and ... Read more

Related support groups: Birth Control, Plan B, Contraception, Obesity, Emergency Contraception, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa

FDA Panel to Discuss Safety of Contraceptive Device Essure

Posted 12 days ago by Drugs.com

The U.S. Food and Drug Administration on Wednesday announced that it would hold a public meeting to discuss the safety of the contraceptive device Essure. Essure – a small metal coil placed via catheter into the fallopian tubes – is the only permanent birth control device approved for use in the United States. The device received approval in 2002, but over the years the FDA has been alerted to thousands of complaints from women who use the device. Those complaints include abdominal pain, menstrual irregularities, headache, fatigue and weight fluctuations. Complaints have also been received regarding "migration," breakage or malposition of the Essure device, the FDA said in a statement published on its website. There have also been a small number of deaths of women potentially linked to Essure, the agency said, and five reports of fetal death after women became pregnant while using the ... Read more

Related support groups: Birth Control, Plan B, Contraception, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa, Plan B One-Step, Mononessa

Hormone Therapy Doesn't Help Memory: Study

Posted 3 Jun 2015 by Drugs.com

WEDNESDAY, June 3, 2015 – Women taking menopausal hormone therapy to relieve symptoms such as hot flashes often hope it will also help their menopause-related memory and thinking problems, but a new study reports it won't. However, oral hormone therapy was linked to mood benefits, the research found. "Hormone therapy is not a panacea, as it was once portrayed to be," said study researcher Carey Gleason, an associate professor at the University of Wisconsin School of Medicine and Public Health. "On the other hand, it is not a poison." Previously, the Women's Health Initiative (WHI) Memory Study ''suggested that hormone therapy was associated with cognitive harm for women age 65 and older," Gleason said. That study also found increased risk of heart attack, strokes and blood clots in postmenopausal women, according to the U.S. National Heart, Lung, and Blood Institute (NHLBI). Today, ... Read more

Related support groups: Plan B, Mirena, Implanon, Provera, Depo-Provera, Nexplanon, Hot Flashes, Microgestin Fe 1/20, Loestrin 24 Fe, Menopausal Disorders, Plan B One-Step, Estradiol, Premarin, Medroxyprogesterone, Progesterone, Estrace, Levonorgestrel, Lo Loestrin Fe, Ethinyl Estradiol, Postmenopausal Symptoms

Exercise May Blunt a Woman's Risk of Lung and Breast Cancer: Studies

Posted 2 Jun 2015 by Drugs.com

TUESDAY, June 2, 2015 – Physical activity may reduce a woman's risk of lung or breast cancer, a pair of new studies suggest. Women seem less likely to either develop or die from lung cancer if they engage in physical activity, and the benefits increase the more a woman stays on the move, Stanford University researchers found. "We saw that as levels of physical activity increase, risk of lung cancer decreased," said lead author Ange Wang, a medical student at Stanford. Even active smokers enjoyed some protective benefit from lung cancer, when compared with couch potatoes who smoked, the researchers said. Meanwhile, a French study found that women may reduce by as much as one-third their risk of developing breast cancer by engaging in vigorous physical exercise. But that benefit did not extend to those who had ever taken hormone replacement therapy. Both studies were presented Monday at ... Read more

Related support groups: Smoking, Microgestin Fe 1/20, Loestrin 24 Fe, Breast Cancer, Estradiol, Premarin, Estrace, Lo Loestrin Fe, Ethinyl Estradiol, Junel Fe 1/20, Lung Cancer, Prempro, Vivelle, Vagifem, Estrace Vaginal Cream, Non-Small Cell Lung Cancer, Climara, Microgestin 1/20, Necon 1/35, Microgestin FE 1.5/30

Hormone Therapy for Menopause Linked to Gastrointestinal Bleeding

Posted 18 May 2015 by Drugs.com

MONDAY, May 18, 2015 – Hormone replacement therapy to relieve menopausal symptoms may raise the risk a bit for serious lower intestinal bleeding, a new study suggests. In the 1990s, millions of American women turned to hormone replacement therapy (HRT) to help ease the symptoms of menopause. But the results of a landmark study called the Women's Health Initiative, released in 2002, found that long-term use of the therapy increased women's risk for breast cancer, as well as their risk for heart attacks and strokes. Use of the regimen fell dramatically soon after. Now researchers say HRT's propensity for clotting, linked to heart attacks and strokes, may also lead to bleeding in the lower intestine. "HRT is an effective treatment, but it does come with risks," said lead researcher Dr. Prashant Singh of Massachusetts General Hospital in Boston. Singh said the risk of any one woman ... Read more

Related support groups: Plan B, Mirena, Implanon, Provera, Depo-Provera, Nexplanon, Hot Flashes, Microgestin Fe 1/20, Loestrin 24 Fe, Menopausal Disorders, Plan B One-Step, Estradiol, Premarin, Medroxyprogesterone, Progesterone, Estrace, Levonorgestrel, Lo Loestrin Fe, Ethinyl Estradiol, Postmenopausal Symptoms

Many Women Unaware of Female-Specific Stroke Symptoms

Posted 7 May 2015 by Drugs.com

WEDNESDAY, May 6, 2015 – Stroke is the third leading cause of death in women, but many are unaware of warning signs and symptoms that are unique to females, a new study says. Of 1,000 women surveyed, only one in 10 was aware that hiccups that occur with unusual chest pain is an early warning sign of stroke in women, said researchers from Ohio State University Wexner Medical Center, in Columbus. Although men and women share some risk factors for stroke – such as smoking, being sedentary and having high blood pressure – others are specific to women, the researchers explained. But only 11 percent of women polled knew that pregnancy, lupus, migraine headaches, birth-control pills and hormone replacement therapy increase their stroke risk, the study found. "I think we have a ways to go when it comes to educating women about stroke and their unique risk factors," Dr. Diana Greene-Chandos, ... Read more

Related support groups: Birth Control, Plan B, Contraception, Migraine, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ischemic Stroke, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa

FDA Should Stop Sales of Essure Contraceptive Implant: Petition

Posted 5 May 2015 by Drugs.com

Bayer's contraceptive implant Essure can cause serious complications and should be taken off the market, says a citizen's petition filed with the U.S. Food and Drug Administration. The FDA approved Essure about 13 years ago after a review process that was fast-tracked because the device was the first alternative to surgical sterilization for women who did not want more children and offered patients a quick recovery, The New York Times reported. Essure is a metal and polyester coil implanted in a woman's fallopian tubes to make her permanently sterile. The procedure can be done in a doctors' office in just 10 minutes. However, since approving Essure, the FDA has received more than 4,000 reports of serious complications, including severe back and pelvic pain, coils that pierced the fallopian tubes and lodged in other organs, and heavy prolonged menstrual periods, The Times reported. ... Read more

Related support groups: Birth Control, Plan B, Contraception, Emergency Contraception, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa, Plan B One-Step

Transgender People Do Not Face Higher Breast Cancer Risk, Study Shows

Posted 11 Mar 2015 by Drugs.com

WEDNESDAY, March 11, 2015 – While some may worry about the long-term health effects of hormonal therapy on transgender people, a new study finds no higher risk of breast cancer in this group than in the general population. Reporting in the journal LGBT Health, the analysis of U.S. veterans' medical records from 1998 to 2013 identified 10 cases of breast cancer in transgender people, according to study author Dr. George Brown, of Mountain Home VA Medical Center in Johnson City, Tenn. The breast cancers tended to be more advanced in people who were born as male and transitioned to female, compared to those who were born female and transitioned to male. Overall, however, transgender people appear to be at no higher odds for developing breast cancer. Speaking in a journal news release, Brown said that when groups of transgender and transsexual people are tracked over time, this has "not ... Read more

Related support groups: Microgestin Fe 1/20, Loestrin 24 Fe, Lo Loestrin Fe, Junel Fe 1/20, Prempro, Necon 1/35, Microgestin 1/20, Microgestin FE 1.5/30, Estratest, Gildess Fe 1/20, Generess Fe, Femhrt, Angeliq, Microgestin 1.5/30, Activella, Climara Pro, Estratest HS, CombiPatch, Jinteli, Loestrin 1/20

More Evidence That Hormone Therapy Might Not Help Women's Hearts

Posted 10 Mar 2015 by Drugs.com

TUESDAY, March 10, 2015 – There's yet another study looking at the potential dangers of hormone replacement therapy for menopausal symptoms, and this one supports the notion that the treatment may not help women's hearts. The research, a review of collected data on the issue, found that hormone replacement therapy (HRT) does not protect most postmenopausal women against heart disease and may even increase their risk of stroke. Also, the findings suggest that the harms and benefits of hormone therapy may vary depending on woman's age when she started the therapy, explained study lead author Dr. Henry Boardman, of the cardiovascular medicine department at the University of Oxford in England. "This 'Timing Hypothesis' may be the critical key to the use of HRT," agreed one expert, Dr. Suzanne Steinbaum, director of women and heart disease at Lenox Hill Hospital in New York City. "For ... Read more

Related support groups: Hot Flashes, Heart Disease, Microgestin Fe 1/20, Loestrin 24 Fe, Menopausal Disorders, Estradiol, Premarin, Estrace, Lo Loestrin Fe, Ethinyl Estradiol, Postmenopausal Symptoms, Junel Fe 1/20, Prempro, Vivelle, Vagifem, Estrace Vaginal Cream, Climara, Microgestin 1/20, Necon 1/35, Microgestin FE 1.5/30

New Study Casts Doubt on Dangers of Hormone Therapy for Hot Flashes

Posted 8 Mar 2015 by Drugs.com

FRIDAY, March 6, 2015 – Hormone replacement therapy for women may not be as potentially risky as previously thought, a new Mayo Clinic review contends. The new study, which evaluated three decades of prior research, concluded that hormone therapy to treat symptoms of menopause doesn't increase overall risk of death or the risk of death from heart attack, stroke or cancer. "This is the latest update of the current evidence," said lead author Dr. Khalid Benkhadra, a research fellow at the Mayo Clinic in Rochester, Minn. "I can say there's no risk of dying from any reason because a woman is taking hormone replacement therapy." The results, Benkhadra said, should allay concerns of some women with debilitating menopausal symptoms who have feared taking hormones. But not everyone is sold on the safety of hormone therapy. Heart and cancer doctors who reviewed the new findings said that ... Read more

Related support groups: Hot Flashes, Microgestin Fe 1/20, Loestrin 24 Fe, Estradiol, Premarin, Estrace, Lo Loestrin Fe, Ethinyl Estradiol, Postmenopausal Symptoms, Junel Fe 1/20, Prempro, Vivelle, Vagifem, Estrace Vaginal Cream, Climara, Microgestin 1/20, Necon 1/35, Microgestin FE 1.5/30, Estratest, Vivelle-Dot

Use of Long-Acting Birth Control Rises Fivefold in a Decade: CDC

Posted 24 Feb 2015 by Drugs.com

TUESDAY, Feb. 24, 2015 – The use of long-acting birth control methods such as IUDs or under-the-skin implants jumped fivefold between 2002 and 2011, according to a new U.S. government report. Among U.S. women aged 15 to 44, the use of these long-term but reversible contraceptives rose from 1.5 percent in 2002 to 7.2 percent in 2011-2013, says the report from the U.S. Centers for Disease Control and Prevention. Researchers from the agency's National Center for Health Statistics (NCHS) believe that these methods are gaining in popularity because of their proven ability to prevent unintended pregnancies. An easing of concerns about safety may be playing a role, too. IUDs (intrauterine devices) were commonly used by women in the 1970s, until safety issues led to a decline in their use. However, since then, IUDs have improved in quality, experts say. Also, over the past 20 years, ... Read more

Related support groups: Birth Control, Plan B, Contraception, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa, Plan B One-Step, Mononessa

Study Ties Hormone Therapy to Increased Ovarian Cancer Risk

Posted 12 Feb 2015 by Drugs.com

THURSDAY, Feb. 12, 2015 – Women who use hormone therapy after menopause – even for just a few years – may have an increased risk of ovarian cancer, according to new research. The new study found that when women used hormone replacement therapy for less than five years after menopause, the risk of ovarian cancer increased by about 40 percent. "We have evidence, proof, that there is a small but real excess risk of cancer of the ovaries with hormone therapy use," said study researcher Sir Richard Peto, professor of medical statistics and epidemiology at the University of Oxford, in England. Peto said the increased risk was significant from a statistical standpoint but emphasized that the risk is a small one. It would mean that for women who take hormone therapy for five years from around age 50, one extra ovarian cancer diagnosis for every 1,000 users would be expected, and one extra ... Read more

Related support groups: Microgestin Fe 1/20, Loestrin 24 Fe, Estradiol, Premarin, Estrace, Lo Loestrin Fe, Junel Fe 1/20, Prempro, Vivelle, Climara, Necon 1/35, Microgestin 1/20, Microgestin FE 1.5/30, Vivelle-Dot, Ovarian Cancer, Gildess Fe 1/20, Generess Fe, Estradiol Patch, Femhrt, Evamist

IUDs, Contraceptive Implants Work Longer Than Thought, Researchers Report

Posted 5 Feb 2015 by Drugs.com

THURSDAY, Feb. 5, 2015 – Hormonal intrauterine devices (IUDs) and contraceptive implants appear to prevent pregnancy one year beyond their approved length of use, according to early results from an ongoing study. Researchers are assessing whether these long-acting forms of birth control may be effective up to three years after their approved length of use. Hormonal IUDs are currently approved for five years and contraceptive implants – small rods inserted into the arm – are currently approved for three years. Both types of contraception were approved by the U.S. Food and Drug Administration. The study, by researchers at the Washington University School of Medicine in St. Louis, will eventually enroll a total of 800 women. These preliminary results were from 263 women who used the hormonal IUD Mirena and 237 women who used the contraceptive implants Implanon and Nexplanon. The women ... Read more

Related support groups: Birth Control, Plan B, Contraception, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa, Plan B One-Step, Mononessa

Better Contraceptive Knowledge Can Aid in Safe Use of Acne Drug: Study

Posted 5 Feb 2015 by Drugs.com

WEDNESDAY, Feb. 4, 2015 – Researchers say giving birth control information to women visiting dermatology clinics can help promote the safe use of the drug isotretinoin, an acne medication known to cause birth defects. Isotretinion was originally sold under the brand name Accutane. That particular brand has been discontinued, according to the U.S. Food and Drug Administration (FDA). However, the drug is still available under other brand names, including Absorica, Amnesteem, Claravis, Myorisan, Sotret and Zenatane. The FDA requires women of childbearing age to sign a pledge that they will use two forms of contraception when taking isotretinoin because the medication is known to cause birth defects. The study included 100 female patients from one dermatology clinic. Their average age was about 27, and nearly two-thirds had a college education. Their knowledge about eight methods of birth ... Read more

Related support groups: Birth Control, Plan B, Contraception, Acne, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa, Plan B One-Step

Modern Birth Control Methods Could Avoid 15 Million Unwanted Pregnancies: Report

Posted 4 Feb 2015 by Drugs.com

WEDNESDAY, Feb. 4, 2015 – If more women had access to modern birth control methods and used them correctly, there would be 15 million fewer unwanted pregnancies in low- and middle-income nations each year, a new study suggests. For women in these countries, unwanted pregnancies can have serious consequences, including death, disease, disability and fewer educational and job opportunities, the researchers noted. Also, many unwanted pregnancies end in abortion. Researchers looked at birth control use by women between the ages of 15 and 49, in 35 countries, between 2005 and 2012. Birth control was defined as modern or traditional. Modern methods included condoms, intrauterine devices, oral and injectable contraceptives, implants, sterilization and breast feeding. Traditional methods included withdrawal and trying to time intercourse when women weren't fertile. The risk of unwanted ... Read more

Related support groups: Birth Control, Plan B, Contraception, Sprintec, Mirena, NuvaRing, Implanon, Provera, Depo-Provera, Tri-Sprintec, Nexplanon, Yasmin, Ortho Tri-Cyclen, Microgestin Fe 1/20, Ortho Evra, Loestrin 24 Fe, Lutera, TriNessa, Plan B One-Step, Mononessa

Page 1 2 3 4 5 Next

Ask a Question

Further Information

Related Condition Support Groups

Acne, Contraception, Birth Control, Abnormal Uterine Bleeding, Endometriosis, Polycystic Ovary Syndrome, Postmenopausal Symptoms, Menstrual Disorders, Prevention of Osteoporosis, Gonadotropin Inhibition

Estrostep Fe Patient Information at Drugs.com